Delivery Order SPE2DB20D3103-SPE2DB25FQ2C1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,712.92 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a firm fixed price ceiling value of $5,468.60. The contract, which is not set-aside, represents a single delivery order with an ultimate completion date of August 19, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a ceiling value of $15,728.80. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens on August 18, 2025, with a ceiling value of $5,204.26. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed from the company's Conshohocken, Pennsylvania facility. The award represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a ceiling value of $225,597.60 under a firm fixed price contract type. This delivery order is a non-set-aside award, meaning it was competitively awarded without restrictions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $5,574.45 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml quantities, valued at $2,424.16. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) prefilled pens valued at $14,830.14. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $11,848.26 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on September 4, 2025, with a completion date of September 5, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $9,330.09 with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, serving federal defense and military healthcare...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2C1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) prefilled pens on September 9, 2025, with a ceiling value of $11,601.27 and an ultimate completion date of September 10, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, meaning it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capacity to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains. This specific order for Ozempic, a diabetes management medication, reflects the company's role in supporting the Defense Health Agency and broader military healthcare supply chains through flexible contract vehicles designed to meet diverse and evolving medical needs across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 9/9/25 |